Clarity Pharmaceuticals Ltd.ASX: CU6

Ceasing to be a substantial holder

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX ·

605 Page 1 20-Oct-2026 Form 605 Corporations Act 2001 Section 671B Notice of ceasing to be a substantial holder To Company Name/Scheme CLARITY PHARMACEUTICALS LTD ACN/ARSN 143 005 341 1. Details of substantial holder (1) Name State Street Corporation and subsidiaries named in paragraph 4 to this...

View Attachment

6ix hasn’t read this filing yet.

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

Later from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases